{"name":"AJENAT PHARMS","slug":"ajenat-pharms","ticker":"","exchange":"","domain":"ajenatpharms.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":172000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Desoxyn","genericName":"METHAMPHETAMINE","slug":"methamphetamine","revenue":172000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"1943-01-01","label":"Desoxyn first approved","drug":"Desoxyn","drugSlug":"methamphetamine","type":"approval","sentiment":"positive"},{"date":"1972-01-01","label":"Tranxene first approved","drug":"Tranxene","drugSlug":"clorazepate","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":172000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Desoxyn","genericName":"METHAMPHETAMINE","slug":"methamphetamine","indication":"Attention deficit hyperactivity disorder","status":"marketed","revenue":172000000}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Tranxene","genericName":"clorazepate","slug":"clorazepate","indication":"Alcohol withdrawal syndrome","status":"marketed"}]}],"pipeline":[{"name":"Desoxyn","genericName":"METHAMPHETAMINE","slug":"methamphetamine","phase":"marketed","mechanism":"Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity.","indications":["Attention deficit hyperactivity disorder","Obesity"],"catalyst":""},{"name":"Tranxene","genericName":"clorazepate","slug":"clorazepate","phase":"marketed","mechanism":"GABA-A receptor alpha-1/beta-2/gamma-2","indications":["Alcohol withdrawal syndrome","Anxiety","Partial Epilepsy Treatment Adjunct"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}